US Stock MarketDetailed Quotes
NRXP NRX Pharmaceuticals
- 2.0800
- +0.0400+1.96%
Close Aug 23 16:00 ET
- 2.1500
- +0.0700+3.37%
Post 20:02 ET
22.66MMarket Cap-776P/E (TTM)
2.1400High2.0500Low37.97KVolume2.1100Open2.0400Pre Close79.33KTurnover0.47%Turnover RatioLossP/E (Static)10.89MShares7.333052wk High-1.23P/B16.73MFloat Cap1.681352wk Low--Dividend TTM8.05MShs Float769.9000Historical High--Div YieldTTM4.41%Amplitude1.6810Historical Low2.0890Avg Price1Lot Size
NRX Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -87.32%1.9M | -92.01%1.32M | -77.09%4.6M | -77.09%4.6M | -51.22%8.9M | -39.02%14.97M | -58.94%16.51M | -27.35%20.05M | -27.35%20.05M | -53.07%18.25M |
| -Cash and cash equivalents | -87.32%1.9M | -92.01%1.32M | -77.09%4.6M | -77.09%4.6M | -51.22%8.9M | -39.02%14.97M | -58.94%16.51M | -27.35%20.05M | -27.35%20.05M | -53.07%18.25M |
| Receivables | 0.00%6K | 0.00%6K | -14.29%6K | -14.29%6K | -98.90%6K | -98.92%6K | --6K | --7K | --7K | --547K |
| -Other receivables | 0.00%6K | 0.00%6K | -14.29%6K | -14.29%6K | -98.90%6K | -98.92%6K | --6K | --7K | --7K | --547K |
| Prepaid assets | -38.17%2.98M | -63.88%1.89M | -60.18%2.28M | -60.18%2.28M | -30.37%4.18M | -34.18%4.81M | 55.06%5.24M | 12.23%5.73M | 12.23%5.73M | -5.45%6.01M |
| Other current assets | ---- | --128K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total current assets | -75.34%4.88M | -84.62%3.35M | -73.31%6.88M | -73.31%6.88M | -47.22%13.09M | -38.95%19.79M | -50.08%21.76M | -21.15%25.8M | -21.15%25.8M | -45.17%24.8M |
| Non current assets | ||||||||||
| Other non current assets | 1,728.57%384K | 1,737.50%441K | 1,952.38%431K | 1,952.38%431K | -8.70%21K | 10.53%21K | 41.18%24K | 40.00%21K | 40.00%21K | 44.46%23K |
| Total non current assets | 1,728.57%384K | 1,737.50%441K | 1,952.38%431K | 1,952.38%431K | -8.70%21K | 10.53%21K | 41.18%24K | 40.00%21K | 40.00%21K | 44.46%23K |
| Total assets | -73.43%5.26M | -82.61%3.79M | -71.66%7.32M | -71.66%7.32M | -47.19%13.11M | -38.92%19.81M | -50.05%21.78M | -21.12%25.82M | -21.12%25.82M | -45.14%24.82M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 67.67%5.02M | 65.92%6.27M | 123.12%4.63M | 123.12%4.63M | 81.96%3.95M | -2.83%2.99M | -12.41%3.78M | -43.69%2.08M | -43.69%2.08M | -61.00%2.17M |
| -accounts payable | 127.44%5.02M | 65.92%6.27M | 123.12%4.63M | 123.12%4.63M | 67.48%3.63M | -28.36%2.21M | -12.41%3.78M | -43.69%2.08M | -43.69%2.08M | -61.00%2.17M |
| -Other payable | ---- | ---- | ---- | ---- | --314K | --786K | ---- | ---- | ---- | ---- |
| Current accrued expenses | -9.94%6.21M | -4.73%5.79M | -9.20%5.24M | -9.20%5.24M | -8.85%5.3M | 73.14%6.9M | 35.97%6.07M | 102.85%5.77M | 102.85%5.77M | 84.70%5.82M |
| Current debt and capital lease obligation | -39.72%7.65M | -44.38%6.78M | 18.93%9.16M | 18.93%9.16M | --10.07M | --12.69M | 2,244.04%12.19M | 1,387.07%7.7M | 1,387.07%7.7M | ---- |
| -Current debt | -39.72%7.65M | -44.38%6.78M | 18.93%9.16M | 18.93%9.16M | --10.07M | --12.69M | 2,244.04%12.19M | 1,387.07%7.7M | 1,387.07%7.7M | ---- |
| Other current liabilities | 13,169.44%4.78M | 4.00%26K | -54.05%17K | -54.05%17K | -82.14%10K | 89.47%36K | -99.04%25K | -99.24%37K | -99.24%37K | -99.79%56K |
| Current liabilities | 4.59%23.66M | -14.53%18.86M | 22.22%19.05M | 22.22%19.05M | 140.33%19.33M | 219.40%22.62M | 85.22%22.06M | 30.71%15.59M | 30.71%15.59M | -77.84%8.04M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.82M | --2.82M | ---- |
| -Long term debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.82M | --2.82M | ---- |
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --2.82M | --2.82M | --0 |
| Total liabilities | 4.59%23.66M | -14.53%18.86M | 3.48%19.05M | 3.48%19.05M | 140.33%19.33M | 219.40%22.62M | 85.22%22.06M | 54.38%18.41M | 54.38%18.41M | -77.84%8.04M |
| Shareholders'equity | ||||||||||
| Share capital | -86.25%11K | -85.71%10K | 29.85%87K | 29.85%87K | 27.94%87K | 19.40%80K | 4.48%70K | 13.56%67K | 13.56%67K | 24.06%68K |
| -common stock | -86.25%11K | -85.71%10K | 25.37%84K | 25.37%84K | 23.53%84K | 19.40%80K | 4.48%70K | 13.56%67K | 13.56%67K | 24.06%68K |
| -Preferred stock | --0 | --0 | --3K | --3K | --3K | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -10.22%-267.57M | -10.96%-259.68M | -13.52%-253.15M | -13.52%-253.15M | -16.95%-248.82M | -19.19%-242.75M | -18.99%-234.04M | -21.69%-223M | -21.69%-223M | -39.56%-212.76M |
| Paid-in capital | 3.87%249.17M | 4.72%244.6M | 4.77%241.33M | 4.77%241.33M | 5.69%242.53M | 4.77%239.89M | 2.31%233.58M | 12.92%230.34M | 12.92%230.34M | 42.21%229.47M |
| Gains losses not affecting retained earnings | 86.36%-3K | -102.83%-3K | ---3K | ---3K | ---22K | ---22K | --106K | --0 | --0 | ---- |
| Total stockholders'equity | -554.95%-18.39M | -5,205.99%-15.07M | -258.36%-11.73M | -258.36%-11.73M | -137.05%-6.22M | -111.08%-2.81M | -100.90%-284K | -64.39%7.41M | -64.39%7.41M | 87.14%16.78M |
| Total equity | -554.95%-18.39M | -5,205.99%-15.07M | -258.36%-11.73M | -258.36%-11.73M | -137.05%-6.22M | -111.08%-2.81M | -100.90%-284K | -64.39%7.41M | -64.39%7.41M | 87.14%16.78M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg